Dr. Jeff Colyer is back with another piece in the Wall Street Journal providing an update on COVID-19 patients being treated with a combination of the drugs hydroxychloroquine (HC) and azithromycin (more commonly known as Z-Pak). Newly emerging data are showing more potential promise that COVID-19 can be treated with these medicines, with patients […]
All too often public health policymakers and officials tend to treat private sector healthcare providers as either a distraction, an impediment or even an active adversary. But that’s shortsighted, according to Novartis head of social business Harald Nusser and Jeffrey Sturchio, CEO at Rabin Martin, a […]
By Erik Sass, TES Editor-in-Chief In so many ways, Theresa May’s tearful final departure as UK prime minister is classic Brexit: long expected but long delayed, it is a dramatic event that changes nothing, an emotional milestone marking progress to nowhere, a final statement that only serves to raise more […]